Designed for trade association, exhibitors, academic institutions and speakers, List and promote your online events
Largest database of verified shows since 2015, Detailed profiles of verified trade shows, conferences and consumer shows. Create your event and attract attendees and exhibitiors, Listing tools for verification, institution and corporation.
Connect with verified event organizers, Listing and RFP tools for verified venue operators.Size events by verified attendee and exhibitor count database
Research verified b2b events by industry and profession, Review virtual exhibitor showcase. Create Profile. Connect with verified event organizers and exhibitors.
Search 900k verified exhibitor database organizedby 2,000+ events since 2018.
It has been estimated that only a fraction of known disease targets have been successfully met with therapeutic options. As our understanding of disease biology continues to outpace our ability to develop therapeutic agents, there is an urgent need to find new ways to unlock a greater portion of this “undruggable” target space. Oligonucleotide and peptide therapeutics have emerged as critical development platforms to meet this challenge, poised to produce highly specific, diverse and safe therapies while addressing a much wider range of targets than traditional small molecules or biologics.
CHI’s Third Annual Oligonucleotide & Peptide Therapeutics (OPT) Boston will once again convene leading developers and technology providers to discuss advances in next-generation oligonucleotide and peptide therapies. This three-day event includes two main conferences covering topics within discovery, delivery, and early clinical studies, as well as a symposium focused on utilizing oligonucleotides and peptides to address rare diseases.
Venue:
Boston Marriott Cambridge
Source : Event Website
| Event Name | City | State | Atendance | Exhibitors | Date |
|---|---|---|---|---|---|
| 2022 Oligonucleotide and Peptide Therapeutics | Boston | Massachusetts | - |  verified |
Mar 15, 2022 |
| 2021 Oligonucleotide and Peptide Therapeutics | Cambridge | Massachusetts | - | - | Mar 02, 2021 |
| Oligonucleotide and Peptide Therapeutics | Cambridge | Massachusetts |  estimated |
- | Mar 17, 2020 |
| Oligonucleotide and Peptide Therapeutics | Boston | Massachusetts | estimated |
- | Mar 26, 2019 |
| Oligonucleotide and Peptide Therapeutics | Boston | Massachusetts | verified |
- | Mar 26, 2018 |
| Event Name | City | State | Atendance | Exhibitors | Date |
|---|---|---|---|---|---|
| American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting | San Diego | California | estimated |
estimated |
Feb 28, 2025 |
| Immuno-Oncology 360 - 2025 | Boston | Massachusetts | verified |
verified |
Mar 24, 2025 |
| AAI 2025 Advanced Course in Immunology - American Association of Immunologists | verified |
verified |
May 03, 2025 | ||
| AAI Immunology 2025 - American Association of Immunologists | Honolulu | Hawaii | estimated |
estimated |
May 03, 2025 |
| Eastern Allergy Conference 2025 | Palm Beach | Florida | estimated |
verified |
May 29, 2025 |
